Jones Financial Companies
IMNM icon

Jones Financial Companies’s Immunome IMNM Stock Holding History

Jones Financial Companies’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$25.9K Hold
1,320
– – ﹤0.01% 3195
2025
Q4 		$28.4K Buy
1,320
+320
+32% +$5.62K ﹤0.01% 2791
2025
Q3 		$11.6K Sell
1,000
-120
-11% -$1.19K ﹤0.01% 3019
2025
Q2 		$9.82K Buy
1,120
+1,000
+833% +$8.2K ﹤0.01% 2882
2025
Q1 		$839 Buy
+120
New +$1.15K ﹤0.01% 3435

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Jones Financial Companies's IMNM Position: Q1 2026 in Review

Jones Financial Companies held its Immunome (IMNM) position steady in Q1 2026 at 1,320 shares worth $25.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3195.

Jones Financial Companies first reported a position in IMNM in Q1 2025 and has held it in 5 quarters since. The position peaked at $28.4K in Q4 2025. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • Jones Financial Companies held 1,320 shares of Immunome worth $25.9K as of Q1 2026.
  • Jones Financial Companies left its Immunome share count unchanged in Q1 2026.
  • Immunome made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #3195 holding.
  • Jones Financial Companies first reported a position in Immunome in Q1 2025 and has held it in 5 quarters since.
  • Jones Financial Companies's Immunome position peaked at $28.4K in Q4 2025.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.